Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 490365, 14 pages
http://dx.doi.org/10.1155/2015/490365
Research Article

Ileal Interposition in Rats with Experimental Type 2 Like Diabetes Improves Glycemic Control Independently of Glucose Absorption

1Department of General, Visceral, Vascular and Paediatric Surgery, University Hospital of Würzburg, Oberdürrbacher Straße 6, 97080 Würzburg, Germany
2Institute of Anatomy and Cell Biology, University of Würzburg, Koellikerstraße 6, 97070 Würzburg, Germany
3Molecular Toxicology Unit, Institute for Medical Research & Occupational Health, Ksaverska Cesta 2, 10000 Zagreb, Croatia
4Department of Molecular Plant Physiology and Biophysics, Julius-von-Sachs-Institute, University of Würzburg, Julius-von-Sachs-Platz 2, 97082 Würzburg, Germany

Received 23 March 2015; Revised 5 June 2015; Accepted 7 June 2015

Academic Editor: Bernard Portha

Copyright © 2015 Christian Ferdinand Jurowich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Buchwald, R. Estok, K. Fahrbach et al., “Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis,” The American Journal of Medicine, vol. 122, no. 3, pp. 248–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. N. V. Christou, J. S. Sampalis, M. Liberman et al., “Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients,” Annals of Surgery, vol. 240, no. 3, pp. 416–424, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Brolin, “Bariatric surgery and long-term control of morbid obesity,” Journal of the American Medical Association, vol. 288, no. 22, pp. 2793–2796, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Steinbrook, “Surgery for severe obesity,” The New England Journal of Medicine, vol. 350, no. 11, pp. 1075–1079, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Ashrafian and C. W. le Roux, “Metabolic surgery and gut hormones—a review of bariatric entero-humoral modulation,” Physiology & Behavior, vol. 97, no. 5, pp. 620–631, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Thaler and D. E. Cummings, “Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery,” Endocrinology, vol. 150, no. 6, pp. 2518–2525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. E. Cummings, “Metabolic surgery for type 2 diabetes,” Nature Medicine, vol. 18, no. 5, pp. 656–658, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. B. Dixon, P. Zimmet, K. G. Alberti, and F. Rubino, “Bariatric surgery: an IDF statement for obese Type 2 diabetes,” Diabetic Medicine, vol. 28, no. 6, pp. 628–642, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Cohen, J. S. Pinheiro, J. L. Correa, and C. A. Schiavon, “Laparoscopic Roux-en-Y gastric bypass for BMI <35 kg/m2: a tailored approach,” Surgery for Obesity and Related Diseases, vol. 2, no. 3, pp. 401–404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. F. Jurowich, P. R. Rikkala, A. Thalheimer et al., “Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes,” Annals of Surgery, vol. 258, no. 1, pp. 89–97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H. S. Koopmans, A. Sclafani, C. Fichtner, and P. F. Aravich, “The effects of ileal transposition on food intake and body weight loss in VMH-obese rats,” The American Journal of Clinical Nutrition, vol. 35, no. 2, pp. 284–293, 1982. View at Google Scholar · View at Scopus
  13. A. Patriti, E. Facchiano, C. Annetti et al., “Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model,” Obesity Surgery, vol. 15, no. 9, pp. 1258–1264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. K. Badman and J. S. Flier, “The gut and energy balance: visceral allies in the obesity wars,” Science, vol. 307, no. 5717, pp. 1909–1914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. K. G. Murphy and S. R. Bloom, “Gut hormones and the regulation of energy homeostasis,” Nature, vol. 444, no. 7121, pp. 854–859, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Chandarana and R. L. Batterham, “Shedding pounds after going under the knife: metabolic insights from cutting the gut,” Nature Medicine, vol. 18, no. 5, pp. 668–669, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. S. Rocca and P. L. Brubaker, “Role of the vagus nerve in mediating proximal nutrient-induced glucagon- like peptide-1 secretion,” Endocrinology, vol. 140, no. 4, pp. 1687–1694, 1999. View at Google Scholar · View at Scopus
  18. D. M. Breen, B. A. Rasmussen, A. Kokorovic, R. Wang, G. W. C. Cheung, and T. K. T. Lam, “Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes,” Nature Medicine, vol. 18, no. 6, pp. 950–955, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Ayala, D. P. Bracy, F. D. James, B. M. Julien, D. H. Wasserman, and D. J. Drucker, “The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action,” Endocrinology, vol. 150, no. 3, pp. 1155–1164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Chai, Z. Dong, N. Wang et al., “Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism,” Diabetes, vol. 61, no. 4, pp. 888–896, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. J. Holst, “Glucagon-like peptide 1 (GLP-1): an intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential,” Trends in Endocrinology & Metabolism, vol. 10, no. 6, pp. 229–235, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Imeryuz, B. C. Yegen, A. Bozkurt, T. Coskun, M. L. Villanueva-Penacarrillo, and N. B. Ulusoy, “Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 273, no. 36, pp. G920–G927, 1997. View at Google Scholar
  23. C. Thomas, A. Gioiello, L. Noriega et al., “TGR5-mediated bile acid sensing controls glucose homeostasis,” Cell Metabolism, vol. 10, no. 3, pp. 167–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. E. M. Wright, D. D. F. L. LOO, and B. A. Hirayama, “Biology of human sodium glucose transporters,” Physiological Reviews, vol. 91, no. 2, pp. 733–794, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Gorboulev, A. Schürmann, V. Vallon et al., “Na+-d-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion,” Diabetes, vol. 61, no. 1, pp. 187–196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. T. Wang, S. Y. Hu, H. D. Gao et al., “Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1,” Annals of Surgery, vol. 247, no. 6, pp. 968–975, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Hu, G. Zhang, D. Sun, H. Han, and S. Hu, “Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model,” Obesity Surgery, vol. 23, no. 9, pp. 1436–1444, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-Z. Liu, D. Sun, G.-Y. Zhang et al., “A high-fat diet reverses improvement in glucose tolerance induced by duodenal-jejunal bypass in type 2 diabetic rats,” Chinese Medical Journal, vol. 125, no. 5, pp. 912–919, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. S. Koopmans, G.-L. Ferri, D. L. Sarson, J. M. Polak, and S. R. Bloom, “The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats,” Physiology & Behavior, vol. 33, no. 4, pp. 601–609, 1984. View at Publisher · View at Google Scholar · View at Scopus
  30. P. K. Chelikani, I. H. Shah, E. Taqi, D. L. Sigalet, and H. H. Koopmans, “Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats,” Obesity Surgery, vol. 20, no. 9, pp. 1281–1288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Mokadem, J. F. Zechner, R. F. Margolskee, D. J. Drucker, and V. Aguirre, “Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency,” Molecular Metabolism, vol. 3, no. 2, pp. 191–201, 2014. View at Publisher · View at Google Scholar
  32. E. Taqi, L. E. Wallace, E. de Heuvel et al., “The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model,” Journal of Pediatric Surgery, vol. 45, no. 5, pp. 987–995, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Zheng, A. C. Shin, N. R. Lenard et al., “Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 297, no. 5, pp. R1273–R1282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. D. E. Cummings, D. S. Weigle, R. Scott Frayo et al., “Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery,” The New England Journal of Medicine, vol. 346, no. 21, pp. 1623–1630, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Bueter, C. Löwenstein, T. Olbers et al., “Gastric bypass increases energy expenditure in rats,” Gastroenterology, vol. 138, no. 5, pp. 1845.e1–1853.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. C. W. le Roux, C. Borg, K. Wallis et al., “Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation,” Annals of Surgery, vol. 252, no. 1, pp. 50–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Nausheen, I. H. Shah, A. Pezeshki, D. L. Sigalet, and P. K. Chelikani, “Effects of sleeve gastrectomy and ileal transposition, alone and in combination, on food intake, body weight, gut hormones, and glucose metabolism in rats,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 305, no. 4, pp. E507–E518, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Y. Zhang, T. T. Wang, Z. Q. Cheng, J. B. Feng, and S. Y. Hu, “Resolution of diabetes mellitus by ileal transposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes,” Canadian Journal of Surgery, vol. 54, no. 4, pp. 243–251, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Patriti, M. C. Aisa, C. Annetti et al., “How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number,” Surgery, vol. 142, no. 1, pp. 74–85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. D. Strader, T. P. Vahl, R. J. Jandacek, S. C. Woods, D. A. D'Alessio, and R. J. Seeley, “Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats,” American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 2, pp. E447–E453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. D. C. Chen, J. S. Stern, and R. L. Atkinson, “Effects of ileal transposition on food intake, dietary preference, and weight gain in Zucker obese rats,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 258, no. 1, pp. R269–R273, 1990. View at Google Scholar · View at Scopus
  42. A. D. Strader, T. R. Clausen, S. Z. Goodin, and D. Wendt, “Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats,” Obesity Surgery, vol. 19, no. 1, pp. 96–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Gaitonde, R. Kohli, and R. Seeley, “The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition,” Journal of Surgical Research, vol. 178, no. 1, pp. 33–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Grueneberger, I. Karcz-Socha, T. Sawczyn et al., “Systematic ileal transposition in Zucker rats shows advantage for long segment distal transposition,” Surgery, vol. 155, no. 1, pp. 165–172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Yan, W. Chen, S. Liu, G. Zhang, D. Sun, and S. Hu, “Myocardial insulin signaling and glucose transport are up-regulated in Goto-Kakizaki type 2 diabetic rats after ileal transposition,” Obesity Surgery, vol. 22, no. 3, pp. 493–501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. A. R. Ramzy, S. Nausheen, and P. K. Chelikani, “Ileal transposition surgery produces ileal length-dependent changes in food intake, body weight, gut hormones and glucose metabolism in rats,” International Journal of Obesity, vol. 38, no. 3, pp. 379–387, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. D. M. Culnan, V. Albaugh, M. Sun, C. J. Lynch, C. H. Lang, and R. N. Cooney, “Ileal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 299, no. 3, pp. G751–G760, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. B. P. Cummings, A. D. Strader, K. L. Stanhope et al., “Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat,” Gastroenterology, vol. 138, no. 7, pp. 2437.e1–2446.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. Y.-S. Lee, S. Shin, T. Shigihara et al., “Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis,” Diabetes, vol. 56, no. 6, pp. 1671–1679, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. C. M. Borg, C. W. L. Roux, M. A. Ghatei, S. R. Bloom, and A. G. Patel, “Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels,” Obesity Surgery, vol. 17, no. 9, pp. 1193–1198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Stock-Damge, M. Aprahamian, F. Raul, J. Marescaux, and N. Scopinaro, “Small-intestinal and colonic changes after biliopancreatic bypass for morbid obesity,” Scandinavian Journal of Gastroenterology, vol. 21, no. 9, pp. 1115–1123, 1986. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Saeidi, L. Meoli, E. Nestoridi et al., “Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass,” Science, vol. 341, no. 6144, pp. 406–410, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Shibazaki, M. Tomae, Y. Ishikawa-Takemura et al., “KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models,” Journal of Pharmacology and Experimental Therapeutics, vol. 342, no. 2, pp. 288–296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. D. R. Powell, M. Smith, J. Greer et al., “LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose,” Journal of Pharmacology and Experimental Therapeutics, vol. 345, no. 2, pp. 250–259, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Bollen, S. Keppens, and W. Stalmans, “Specific features of glycogen metabolism in the liver,” Biochemical Journal, vol. 336, no. 1, pp. 19–31, 1998. View at Google Scholar · View at Scopus
  56. J. Girard, P. Ferré, and F. Foufelle, “Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes,” Annual Review of Nutrition, vol. 17, pp. 325–352, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Agius, “Glucokinase and molecular aspects of liver glycogen metabolism,” Biochemical Journal, vol. 414, no. 1, pp. 1–18, 2008. View at Google Scholar · View at Scopus
  58. R. L. Atkinson, J. H. Whipple, S. H. Atkinson, and C. C. Stewart, “Role of the small bowel in regulating food intake in rats,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 11, no. 3, pp. R429–R433, 1982. View at Google Scholar · View at Scopus
  59. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Junod, A. E. Lambert, W. Stauffacher, and A. E. Renold, “Diabetogenic action of streptozotocin: relationship of dose to metabolic response,” The Journal of Clinical Investigation, vol. 48, no. 11, pp. 2129–2139, 1969. View at Publisher · View at Google Scholar · View at Scopus
  61. D. Balen, M. Ljubojević, D. Breljak et al., “Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody,” American Journal of Physiology—Cell Physiology, vol. 295, no. 2, pp. C475–C489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Kohli, M. Kirby, K. D. R. Setchell et al., “Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 299, no. 3, pp. G652–G660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. M. H. Ulshen and C. A. Herbst, “Effect of proximal transposition of the ileum on mucosal growth and enzyme activity in orally nourished rats,” The American Journal of Clinical Nutrition, vol. 42, no. 5, pp. 805–814, 1985. View at Google Scholar · View at Scopus
  64. H. Johannessen, Y. Kodama, C.-M. Zhao et al., “Eating behavior and glucagon-like peptide-1-producing cells in interposed ileum and pancreatic islets in rats subjected to ileal interposition associated with sleeve gastrectomy,” Obesity Surgery, vol. 23, no. 1, pp. 39–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Colagiuri, “Diabesity: therapeutic options,” Diabetes, Obesity and Metabolism, vol. 12, no. 6, pp. 463–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. R. L. Prigeon, S. Quddusi, B. Paty, and D. A. D'Alessio, “Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect,” American Journal of Physiology—Endocrinology and Metabolism, vol. 285, no. 4, pp. E701–E707, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Zhao, P. Parikh, S. Bhashyam et al., “Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts,” Journal of Pharmacology and Experimental Therapeutics, vol. 317, no. 3, pp. 1106–1113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. A. T. Stearns, A. Balakrishnan, and A. Tavakkolizadeh, “Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 297, no. 5, pp. G950–G957, 2009. View at Publisher · View at Google Scholar · View at Scopus